Pulmonary vascular complications of chronic airway obstruction in children.

OBJECTIVE To study the clinical presentation, treatment, and outcome of pulmonary artery hypertension (PAH) that develops in children with chronic airway obstruction. DESIGN Case study. SETTING Academic tertiary care children's hospital. PATIENTS A 3-year (October 1, 1992, to September 30, 1995) review of the medical records of all children with chronic airway obstruction in whom PAH developed. MAIN OUTCOME MEASURE The clinical course, including objective laboratory data to measure PAH (cardiac catheterization, echocardiography, electrocardiography) both before and after treatment. RESULTS Pulmonary artery hypertension developed in 18 patients. It was diagnosed using cardiac catheterization in 13 patients and echocardiography in 5 patients. Obstructive problems include chronic lung disease (9 patients), tracheobronchomalacia (6 patients), adenotonsillar hypertrophy (5 patients), laryngomalacia (4 patients), macroglossia (5 patients), subglottic stenosis (2 patients), and pharyngeal collapse (2 patients). Nine patients were born prematurely and 7 had Down syndrome. Treatments included tracheotomy (7), adenotonsillectomy (5), adenoidectomy (3), laser epiglottoplasty (1), and supplemental oxygen (12). Fourteen patients had documented improvement of PAH as seen from the cardiac catheterization, echocardiography, or electrocardiography findings; in 4 patients, PAH worsened (3 deaths). CONCLUSIONS Chronic airway obstruction may lead to PAH. In this study, PAH was more likely to develop in premature infants or children with Down syndrome and cardiac anomalies. Surgery or supplemental oxygen will usually improve PAH, but fixed and irreversible PAH developed in patients with the most severe airway disease.

[1]  Q. Si,et al.  Role of collagen metabolism changes in the pathogenesis of pulmonary hypertension in rats and its reversibility. , 1994, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[2]  D. Sajkov,et al.  Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. , 1994, American journal of respiratory and critical care medicine.

[3]  L. Laks Pulmonary arterial pressure in sleep apnea. , 1993, Sleep.

[4]  E. Sforza,et al.  Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients. , 1989, Chest.

[5]  J. Krieger,et al.  Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. , 1988, The American review of respiratory disease.

[6]  L. Reid,et al.  Structure and function in pulmonary hypertension. New perceptions. , 1986, Chest.

[7]  H. Moldofsky,et al.  Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. , 2015, The American review of respiratory disease.

[8]  A. Gest,et al.  Inspiratory airway obstruction does not affect lung fluid balance in lambs. , 1985, Journal of applied physiology.

[9]  F. Jackson,et al.  Laryngospasm-induced pulmonary edema. , 1980, Chest.

[10]  R. Bland,et al.  Alveolar Hypoxia Increases Lung Fluid Filtration in Unanesthetized Newborn Lambs , 1980, Circulation research.

[11]  J. W. Bland,et al.  Pulmonary hypertension and congestive heart failure in children with chronic upper airway obstruction. New concepts of etiologic factors. , 1969, The American journal of cardiology.

[12]  J. Hanson,et al.  Hypertrophied adenoids causing pulmonary hypertension and severe congestive heart failure. , 1967, The New England journal of medicine.

[13]  J. Vogel,et al.  The Role of Hydrogen Ion Concentration in the Regulation of Pulmonary Arterial Pressure: Observations in a Patient with Hypoventilation and Obesity , 1965, Circulation.

[14]  D. Simmons,et al.  Effect of blood gases and acid-base disturbances on the pulmonary circulation. , 1965, Diseases of the chest.

[15]  J. Vogel,et al.  PULMONARY HYPERTENSION. INDIVIDUAL AND SPECIES VARIABILITY RELATIVE TO VASCULAR REACTIVITY. , 1963, American heart journal.

[16]  J. Vogel,et al.  Pulmonary hypertension on exertion in normal man living at 10,150 feet (Leadville, Colorado). , 1962, Medicina thoracalis.

[17]  P. Wood Diseases of the Heart and Circulation , 1902, The Hospital.